Velma Murry, PhD, University Distinguished Professor, named to NIH National Advisory Mental Health Council
Velma McBride Murry, PhD, Vanderbilt University Distinguished Professor of Health Policy and Peabody College, was recently appointed to the National Institutes of Health National Advisory Mental Health Council, an appointment approved by the U.S. Congress.
Child Health Poll: Tennessee Parents Trust Their Children’s Health Care Providers the Most for Information About Vaccines
New analyses of the latest annual Tennessee
Study: Risk of flu spread within households more than doubles over pre-pandemic era
New research published by the Journal of the American Medical Association from Vanderbilt University Medical Center investigators found that the household spread of flu during the 2021-2022 season was more than twice as high as it was prior to the COVID-19 pandemic.
Complementary research, resources, policies improve outcomes for those with substance use disorders: Panel
by Jill Clendening
Researchers recommend ways to measure ‘spillover effects’ on families, caregivers
Imagine the unthinkable: A child diagnosed with cancer who suddenly needs extensive treatment and care for a lengthy period. Researchers have long studied the economic value of that care (e.g., outcomes relative to cost) but measuring the impact of patient illness on parents or caregivers has been underestimated and inconsistently incorporated into economic evaluations.
Hospital readmissions tied to supply of care options in communities around hospitals
A new study in Health Affairs from researchers at Vanderbilt Univer
Filling multiple opioid prescriptions after childbirth is associated with a 50% increase in the risk of maternal death
In a new study led by Vanderbilt University Medical Center researchers, women who filled two or more prescriptions for opioids after childbirth faced a 46% greater risk of death than women who did not.
New study in NEJM illustrates how much it would cost for cancer drugs covered under Medicare Part D
A new study in the New England Journal of Medicine highlights how some older Americans diagnosed with cancer can face unlimited out-of-pocket spending for prescription drugs under the current structure of the Medicare Part D benefit.
